Patent US3882248A successfully refreshed from Google Patents.
← Back to Patent Explorer
US3882248A Expired / Lapsed US ⏱️ 0.0 years remaining

Gallstone solubilizer

Assignee: Hisamitsu Pharmaceutical Co Inc
•
Filing: 1974-01-28
•
Granted: 1975-05-06
•
Expires: 1994-01-28
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A gallstone solubilizer containing a monoterpene, a sesquiterpene, an essential oil containing such a terpene or a mixture thereof as active ingredient.

Inventors

  • 👤 Hirotsune Igimi
  • 👤 Hiroyuki Ide

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-28 13:18
CPC Classifications
A; A61; A61K; A61K9/00; A61K9/0012; A61K9/0019; A61K31/00; A61K31/01; A61K31/015; A61K47/00; A61K47/06; A61K47/26

Claims Analysis

Total Claims: 3
Claim 1
Independent Claim 79 words
A GALLSTONE SOLUBILIZER FOR DISSOLVING CHOLESTEROL-TYPE GALLSTONES BY DIRECT INJECTION INTO THE AFFECTED PARTS OF THE PATIENT THROUGH A MEDICAL CATHETHER, COMPRISING: A. 99.8 - 70% (W/V) OF A MEMBER SELECTED FROM THE GROUP B. 0.1 - 15% (W/V) OF A MEMBER SELECTED FROM THE GOUP CONSISTING OF SORBITAN MONOLAURATE, SORRBITAN MONOOLEATE AND POLYOXETHYLENE SORBITAN MONOOLEATE HAVING ABOUT 20 OXYETHYLENE UNITS; AND C. 0.01 - 15% (W/V) OF A MEMBER SELECTED FROM THE GROUP CONSISTING OF ETHANOL AND WATER.
Claim 2
Dependent Claim 79 words
A GALLSTONE SOLUBILIZER FOR DISSOLVING CHOLESTEROL-TYPE GALLSTONES BY DIRECT INJECTION INTO THE AFFECTED PARTS OF THE PATIENT THROUGH A MEDICAL CATHETHER, COMPRISING: A. 99.8 - 70% (W/V) OF A MEMBER SELECTED FROM THE GROUP B. 0.1 - 15% (W/V) OF A MEMBER SELECTED FROM THE GOUP CONSISTING OF SORBITAN MONOLAURATE, SORRBITAN MONOOLEATE AND POLYOXETHYLENE SORBITAN MONOOLEATE HAVING ABOUT 20 OXYETHYLENE UNITS; AND C. 0.01 - 15% (W/V) OF A MEMBER SELECTED FROM THE GROUP CONSISTING OF ETHANOL AND WATER.
Claim 3
Dependent Claim 30 words
A method of eliminating cholesterol-type gallstones comprising infusing into the bile duct of the patient the gallstone solubilizer of claim 1 in an amount sufficient to eliminate the cholesterol-type gallstones.

References Cited (Backward Citations)

No citation records indexed.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1978-05-05 1978-11-04 1979-05-06 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1982-05-05 1982-11-04 1983-05-06 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1986-05-05 1986-11-04 1987-05-06 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag